| Literature DB >> 27163422 |
Bárbara Maria Hermes1, Dannuey Machado Cardoso2, Tiago José Nardi Gomes3, Tamires Daros dos Santos1, Marília Severo Vicente1, Sérgio Nunes Pereira4, Viviane Acunha Barbosa5, Isabella Martins de Albuquerque5.
Abstract
OBJECTIVE: To investigate the efficiency of short-term inspiratory muscle training program associated with combined aerobic and resistance exercise on respiratory muscle strength, functional capacity and quality of life in patients who underwent coronary artery bypass and are in the phase II cardiac rehabilitation program.Entities:
Mesh:
Year: 2015 PMID: 27163422 PMCID: PMC4614931 DOI: 10.5935/1678-9741.20150043
Source DB: PubMed Journal: Rev Bras Cir Cardiovasc
Demographic and clinical characteristics of patients participating in the study.
| Baseline characteristics | GCR
( | GCR+IMT
( |
|
|---|---|---|---|
| Age (years) | 59.5±8.7 | 55.2±7.9 | 0.313 |
| Male gender, n (%) | 10 (83.3) | 7 (58.3) | 0.178 |
| BMI (Kg/m2) | 28.4±3.8 | 30.7±4.4 | 0.274 |
| Diabetes, n (%) | 4 (33.33) | 3 (25.0) | 0.500 |
| Hypertension, n (%) | 4 (33.33) | 5 (41.6) | 0.312 |
| Ejection fraction (%) | 65.2±9.9 | 63.5±3.6 | 0.640 |
| NYHA | |||
| I, n (%) | 2 (16.7) | 3 (25.0) | 0.849 |
| II, n (%) | 8 (66.7) | 6 (50.0) | 0.408 |
| III, n (%) | 2 (16.7) | 3 (25.0) | 0.849 |
| Extent of disease (%) | |||
| 2-vessel | 54.3 | 50.5 | 0.285 |
| 3-vessel | 45.7 | 49.5 | |
| Extracorporeal circulation, n (%) | 12 (100) | 12 (100) | - |
| Duration of hospitalization after surgery (days) | 6.7±1.7 | 7.1±1.5 | 0.657 |
| Peak VO2 (mL.Kg1.min-1) | 26.0±5.6 | 25.5±3.7 | 0.802 |
| Peak VO22 (% predicted) | 88.1±23.0 | 86.4±16.0 | 0.836 |
| PImax (c2mH2O) | 72.0±8.1 | 67.8±9.0 | 0.782 |
| PImax (% predicted) | 71.4±13.8 | 70.4±11.1 | 0.856 |
| PEmax (cmH2O) | 87.3±11.0 | 86.6±25.9 | 0.936 |
| PEmax (% predicted) | 80.2±13.9 | 86.1±27.7 | 0.518 |
| MLwHFQ (score) | 39.9±12.6 | 41.0±19.0 | 0.871 |
| Medication, n (%) | |||
| Acetylsalicylic acid | 8 (66.6) | 6 (50.0) | 0.408 |
| Clopidogrel or triclopidine | 2 (16.7) | 1 (8.3) | 0.500 |
| Statin | 6 (50.0) | 6 (50.0) | 1.000 |
| Diuretics | 4 (33.3) | 3 (25.0) | 0.500 |
| Warfarin | 1 (8.3) | 2 (16.7) | 0.500 |
| ACEI or ARB | 4 (33.3) | 5 (41.6) | 0.500 |
| Beta-blockers | 8 (66.6) | 9 (75.0) | 1.000 |
Data are expressed as mean ± standard deviation or absolute values and percentages.
ACEI=angiotensin-converting enzyme inhibitor; ARB=angiotensin II receptor blocker; BMI=body mass index; GCR=cardiac rehabilitation group; GCR+IMT=cardiac rehabilitation group + inspiratory muscle training program; MLwHFQ=Minnesota living with heart failure questionnaire; NYHA=New York Heart Association; Peak VO2=peak oxygen consumption; PEmax=maximal expiratory pressure; PImax=maximal inspiratory pressure
Comparison of respiratory muscle strength between groups.
| Variables | GCR (n=12) | GCR+IMT (n=12) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Variation | Pre | Post | Variation |
|
| ||
| PEmax (cmH2O) | 87.3±11.0 | 89.8±10.5 | 2.3±0.8 | 0.004 | 86.6±25.9 | 108.1 ±17.1 | 21.5±8.5 | <0.001 | <0.001 |
| PEmax (% predicted) | 80.2±13.9 | 82.2±15.6 | 2.5±0.8 | 0.038 | 86.1±27.7 | 108.1±21.1 | 22.0±7.7 | <0.001 | <0.001 |
| PImax (cmH2O) | 72.0±8.3 | 77.0±5.8 | 4.9±0.2 | <0.001 | 67.8±9.0 | 96.7±21.3 | 28.9±7.9 | <0.00 | <0.001 |
| PImax (% predicted) | 71.4±13.8 | 76.4±12.8 | 4.7±0.9 | <0.001 | 70.4±11.1 | 99.6±16.7 | 29.1±5.6 | 1 <0.001 | <0.001 |
Data are expressed as mean ± standard deviation.
GCR=cardiac rehabilitation group; GCR+IMT=cardiac rehabilitation group + inspiratory muscle training program; PEmax=maximal expiratory pressure; Pimax=maximal inspiratory pressure
P-value derived using paired Student’s t-test, after checking for normal distributions.
P-value derived using independent Student’s t-test for comparison of variation between the groups.
Fig. 1Comparison of peak oxygen consumption (peak VO2) between groups.
Fig. 2Comparison of peak oxygen consumption (% predicted) between groups.
Fig. 3Comparison of change in QoL score, assessed with Minnesota Living with Heart Failure questionnaire (MLwHFQ), between groups.
|
| |
|---|---|
| CABG | Coronary artery bypass |
| CAD | Coronary artery disease |
| CRP | Cardiac rehabilitation program |
| GCR | Group of cardiac rehabilitation |
| IMT | Inspiratory muscle training |
| Peak VO2 | Peak oxygen consumption |
| PEmax | Maximal expiratory pressure |
| PImax | Maximal inspiratory pressure |
| RMS | Respiratory muscle strength |
|
| |
|---|---|
| BMH | Analysis and/or interpretation of data; final approval of the manuscript; study design; implementation of projects and/ or experiments; manuscript writing or critical review of its content |
| DMC | Analysis and/or interpretation of data; statistical analysis; final approval of the manuscript; manuscript writing or critical review of its content |
| TJNG | Final approval of the manuscript; study design; implemen-tation of projects and/or experiments; manuscript writing or critical review of its content |
| TDS | Final approval of the manuscript; implementation of projects and/or experiments; manuscript writing or critical review of its content |
| MSV | Final approval of the manuscript; implementation of projects and/or experiments; manuscript writing or critical review of its content |
| SNP | Final approval of the manuscript; study design; manuscript writing or critical review of its content |
| VAB | Final approval of the manuscript; study design; manuscript writing or critical review of its content |
| IMA | Analysis and/or interpretation of data; Statistical analysis; final approval of the manuscript; study design; manuscript writing or critical review of its content |